Systematic research to overcome newly emerged multidrug-resistant bacteria

Yoshichika Arakawa1

  • 1Department of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Microbiology and Immunology
|February 19, 2020
PubMed

Insights

This research details the discovery of novel antibiotic resistance genes, including beta-lactamases and 16S ribosomal RNA methyltransferases, in various bacteria. It also introduces a simple disk test for identifying metallo-beta-lactamase producing bacteria.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The emergence of antibiotic resistance poses a significant threat to public health.
  • Understanding the genetic basis and origins of resistance mechanisms is crucial for developing effective countermeasures.
  • Klebsiella pneumoniae and Klebsiella oxytoca are key Gram-negative bacteria often implicated in the spread of resistance.

Purpose of the Study:

  • To identify and characterize novel antibiotic resistance genes and enzymes in various bacterial species.
  • To investigate the evolutionary origins of antibiotic resistance genes, such as TEM-1 beta-lactamase.
  • To develop rapid diagnostic methods for detecting specific resistance mechanisms, like metallo-beta-lactamases.

Main Methods:

  • Amino acid sequence analysis to compare beta-lactamases.
  • Identification and characterization of plasmid-mediated resistance genes.
  • Development of the sodium mercaptoacetic acid (SMA)-disk test for metallo-beta-lactamase detection.
  • PCR-based typing for bacterial strain identification.

Main Results:

  • Discovery of chromosomal beta-lactamases (LEN-1, KOXY) related to plasmid-mediated TEM-1.
  • Identification of numerous novel plasmid-mediated serine-type beta-lactamases (e.g., MOX-1, SHV-24, CTX-M-64).
  • First identification of exogenously acquired metallo-beta-lactamases (IMP-1, SMB-1) in Serratia marcescens.
  • First identification of plasmid-mediated 16S ribosomal RNA methyltransferases (RmtA-C, NpmA) conferring high-level aminoglycoside resistance.
  • Discovery of plasmid-mediated quinolone efflux pump (QepA) and fosfomycin-inactivating enzymes (FosA3, FosK).
  • Characterization of resistance in Streptococcus agalactiae, Mycoplasma pneumoniae, Campylobacter jejuni, Helicobacter pylori, and Acinetobacter baumannii.
  • Development of the SMA-disk test for simple identification of MBL-producing bacteria.

Conclusions:

  • The study highlights the diverse and evolving nature of antibiotic resistance mechanisms in bacteria.
  • Plasmid-mediated genes play a significant role in the dissemination of resistance.
  • Novel diagnostic tools are essential for timely detection and control of resistant pathogens.
  • Further research is needed to understand the clinical and epidemiological impact of these newly identified resistance determinants.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
850
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K